• Research Faculty

  • A photo of Raouf Amin.

    Raouf S. Amin, MD Director, Division of Pulmonary Medicine

    is interested in cardiovascular morbidity of sleep disordered breathing in children.


    A photo of Thomas F. Boat.

    Thomas F. Boat, MD Director, CFWELL, Division of Pulmonary Medicine

    enhances wellness for families with cystic fibrosis and improves health outcomes by promoting nurturing environments for young children.


    A photo of Ronald Bukovic.
    A photo of Barbara Chini.

    Barbara Chini, MD Director, Pulmonary Fellowship Program


    A photo of John Clancy.

    John P. Clancy, MD Gunnar Esiason/Cincinnati Bell Chair

    focuses primarily on airway epithelial biology, examining strategies to treat cystic fibrosis and to normalize protease dysregulation in lung inflammatory disorders. The goals of our research program are 1) to examine strategies to restore activity to mutant, disease-causing CFTR mutations, 2) to develop new biomarkers of CFTR activity, and 3) to investigate novel inflammatory pathways.


    A photo of Daniel Grossoehme.

    Daniel H. Grossoehme Chaplain, Division of Pulmonary Medicine

    researches adherence, spirituality and religion, chronic illness coping and HRQoL.
    Visit the Grossoehme Lab.


    A photo of Theresa Guilbert.

    Theresa W. Guilbert, MD, MS Associate Director, Asthma Center

    is a pediatric pulmonologist who has research interests in the area of early life risk factors, exposures, and environment interactions that lead to the development of early childhood asthma and recurrent wheezing. Much of Dr. Guilbert’s research experience has been with National Institutes of Health sponsored multi-center trials and networks. Another area of research interest is using clinical electronic medical data.


    A photo of William D. Hardie.
    A photo of Carolyn Kercsmar.

    Carolyn M. Kercsmar, MD Co-Director, Division of Pulmonary Medicine


    A photo of Satish Madala.

    Satish K. Madala, PhD

    is assistant professor in the Division of Pulmonary Medicine at Cincinnati Children’s within the UC Department of Pediatrics. His basic research is focused on studying molecular mechanisms in pulmonary fibrosis. His current funded research programs specifically focuses on multiple stromal cell subsets and cytokines that contribute to the initiation and progression of fibrosis in the lung.
    Visit the Madala Lab.


    A photo of Karen McDowell.

    Karen M. McDowell, MD Director, Infant Pulmonary Function Lab


    A photo of Gary Lewis McPhail.

    Gary Lewis McPhail, MD Cystic Fibrosis Center Director, Division of Pulmonary Medicine


    A photo of AP Naren.

    Anjaparavanda P. (AP) Naren, PhD Thomas Boat Chair in Cystic Fibrosis Research

    is a physiologist whose lab studies the cellular and molecular mechanisms of how protein-protein interactions regulate the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel in diseases such as cystic fibrosis and secretory diarrhea.


    A photo of Marc Schecter.

    Marc G. Schecter, MD Medical Director, Pediatric Lung Transplant Program

    is a pediatric pulmonologist with a special interest in pediatric lung transplantation. His research has focused on the pulmonary microbiome and lung transplant, health related quality of life following lung transplant, and other clinical studies investigating lung transplantation in children.


    A photo of Michael Seid.

    Michael Seid, PhD Director, Health Outcomes and Quality Care Research, Pulmonary Medicine and James M. Anderson Center for Health Systems Excellence

    The basic science behind what to do to improve health include genetics, biology, and chemistry, and physiology; the basic science behind how to do it right is behavioral and social science. Dr. Seid's Lab applies behavioral and social science to answer the question ‘What does it take to make sure the right treatment gets to the right child in the right way at the right time, every time?’ The lab takes a noncategorical approach to answering this question, as there are many more similarities than differences across diseases in what it takes to get things right. They also recognize that answering this question requires expertise from many areas: patients and families; clinicians; social scientists like psychologists, sociologists, economists, and anthropologists; designers; story-tellers and artists; systems engineers; organizers; technologists; health informaticians; and epidemiologists and other statisticians. 

    Visit the Seid Lab.


    A photo of Robert Wood.

    Robert E. Wood, PhD, MD Director, Pulmonary Bronchoscopy Department


    A photo of Jason Woods.

    Jason C. Woods, PhD Director, Center for Pulmonary Imaging Research

    is an imaging scientist who focuses on basic and translational pulmonary MRI and CT. His lab studies new methods for in-vivo assessment of regional pulmonary function, microstructure and physiology using hyperpolarized gases (3He and 129Xe) and 1H MRI, in addition to multi-volume CT. As new therapeutics for pulmonary diseases are developed, these new methods will be used for efficacy assessment and potential image guidance.


    A photo of Assem G. Ziady.

    Assem G. Ziady, PhD Director, The Cystic Fibrosis Biomarker Analysis and Assay Development RDP Core

    uses biochemistry, proteomics, and molecular biology to study the interaction between the antioxidant response element (ARE) and inflammatory signaling in epithelial cells, with a major focus on Nrf2 dysfunction in cystic fibrosis and COPD. He also designs nonviral DNA vectors for lung delivery and examine their delivery mechanistically. The overall goal of his lab is to understand the systems biology of inflammation in chronic lung disease.
    Visit the Ziady Lab.